Publications by authors named "Stephanie Delluc"

Claim this Profile
[
[The prediction of immunogenicity of therapeutic proteins].
Bernard Maillère, Stéphanie Delluc, Gilles Ravot

Med Sci (Paris)· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors.
Stephanie Delluc, Gilles Ravot, Bernard Maillere

FASEB J· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the preexisting CD4 T-cell repertoire specific for human erythropoietin reveals its immunogenicity potential.
Stéphanie Delluc, Gilles Ravot, Bernard Maillere

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.
Stéphanie Delluc, Patricia Hachem, Sylvie Rusakiewicz, Auguste Gaston, Carmen Marchiol-Fournigault

Cancer Immunol Immunother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method.
Stéphanie Delluc, Léa Tourneur, Didier Fradelizi, Marie-Thérèse Rubio, Carmen Marchiol-Fournigault

Cancer Immunol Immunother· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro.
Stéphanie Delluc, Léa Tourneur, Anne-Sophie Michallet, Charlotte Boix, Bruno Varet

Haematologica· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy.
Monique Gannagé, Michal Abel, Anne-Sophie Michallet, Stéphanie Delluc, Marion Lambert

J Immunol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome.
Léa Tourneur, Stéphanie Delluc, Vincent Lévy, Françoise Valensi, Isabelle Radford-Weiss

Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis